Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00651430
Other study ID # sor462807ctil
Secondary ID MB4628
Status Completed
Phase N/A
First received January 14, 2008
Last updated June 10, 2010
Start date March 2008
Est. completion date May 2010

Study information

Verified date December 2007
Source Soroka University Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

Adults suffer from Osteoarthrosis of hip joint that willing to participate in the study will be tested with well-established measuring techniques of Balance control using force plate before 3 month and 6 month after Total Knee Arthroplasty (THA) in the movement and Rehabilitation Laboratory at BGU. An automated algorithm will be used to extract standardized stabilogram-diffusion parameters from each of the COP data sets collected during quiet standing. These parameters include diffusion coefficients, critical displacement, critical time and scaling exponents for both lateral and anterior-posterior sway directions (Collins & De Luca, 1993). Each of the Times (before 3 month and 6 month after the THA) in two task conditions (eyes closed and eyes close conditions). Participants will be required to stand on the platform 10 times for 30 s For each trial, they will be instructed to sway as little as possible. In addition step execution test and Late life function and disability questionnaires will be also examined.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 2010
Est. primary completion date May 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria:

- Able to stand safely for 30 seconds

- Able to walk independently

- Hip OA prior THA

Exclusion Criteria:

- Stroke or other neurological diseases

- Minimal score 24 or higher

- Blindness

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Soroka Medical Center Beer-Sheva
Israel SorokaUMC Beer-Sheva

Sponsors (1)

Lead Sponsor Collaborator
Soroka University Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary SDF parameters before, 3 month and 6 month after the THA No
Secondary Late Life Function and disability, Fall efficacy scale, step execution test before 3 month and 6 month after No